Evogene Discloses That Another Nasdaq 180-Day Period For Regaining Minimum Bid Price Requirement Has Been Extended Until March 29, 2027
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) (the "Company", "Evogene"), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural
Share
Why It Matters
Evogene got more time to raise its stock price. The company has until March 2027 to meet Nasdaq rules.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.